Maruishi Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Maruishi Pharmaceutical Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10789
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Maruishi Pharmaceutical Co Ltd (Maruishi) is a pharmaceutical company that develops and sells medical drugs. The company offers products in the fields of perioperative and infection control. Its products include anesthetics, perioperative drugs, pharmacopoeia drugs, and disinfectants and antiseptics. Maruishi carries out research and development and sales promotional activities for anesthetics and perioperative drugs. The company also conducts structural analysis and synthetic studies of various metabolite and degradant products. It provides physicochemical studies and formulation design through its laboratories. The company has operations in Japan, the US and China. Maruishi is headquartered in Osaka, Japan.

Maruishi Pharmaceutical Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Maruishi Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Maruishi Pharma to Acquire Five Injectable Brands from Ono Pharma 11
Partnerships 12
Daiichi Sankyo Enters into Agreement with Maruishi Pharma 12
Licensing Agreements 13
Maruishi Pharma Enters into Licensing Agreement with Sumitomo Dainippon Pharma 13
Cara Therapeutics Enters Into Licensing Agreement With Maruishi Pharma For CR845 14
Maruishi Pharmaceutical Co Ltd – Key Competitors 16
Maruishi Pharmaceutical Co Ltd – Key Employees 17
Maruishi Pharmaceutical Co Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Maruishi Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Maruishi Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Maruishi Pharma to Acquire Five Injectable Brands from Ono Pharma 11
Daiichi Sankyo Enters into Agreement with Maruishi Pharma 12
Maruishi Pharma Enters into Licensing Agreement with Sumitomo Dainippon Pharma 13
Cara Therapeutics Enters Into Licensing Agreement With Maruishi Pharma For CR845 14
Maruishi Pharmaceutical Co Ltd, Key Competitors 16
Maruishi Pharmaceutical Co Ltd, Key Employees 17
Maruishi Pharmaceutical Co Ltd, Other Locations 18
Maruishi Pharmaceutical Co Ltd, Subsidiaries 18

List of Figures
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Maruishi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Maruishi Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Maruishi Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Reach Subsea ASA (REACH):企業の財務・戦略的SWOT分析
    Reach Subsea ASA (REACH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Medikit Co Ltd (7749):企業の財務・戦略的SWOT分析
    Summary Medikit Co Ltd (Medikit) is a medical equipment provider that offers vascular devices. The company offers IV catheter, hemodialysis and intervention products. Its products include supercath Z3V, supercath 5 safety IV catheter, supercath AZ, supercath CLS, i-works, seiha, parent plus, parent …
  • Bisalloy Steel Group Ltd:企業の戦略・SWOT・財務分析
    Bisalloy Steel Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Bisalloy Steel Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Flynn Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Flynn Pharma Ltd (Flynn Pharma) is a pharmaceutical company that manufactures and markets barbiturate products, and oral and injectable antibiotics. The company’s products include cefuroxime, circadin, distaclor, keflex, medikinet tablets, medikinet XL capsules, nebcin, nizatidine, phenytoin …
  • Formosa Petrochemical Corp (6505):企業の財務・戦略的SWOT分析
    Formosa Petrochemical Corp (6505) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • IHC Engineering Business Ltd:企業の戦略・SWOT・財務情報
    IHC Engineering Business Ltd - Strategy, SWOT and Corporate Finance Report Summary IHC Engineering Business Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Beacon Industries Inc.:企業の戦略・SWOT・財務情報
    Beacon Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Beacon Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • AbbVie Inc (ABBV):企業の財務・戦略的SWOT分析
    AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Approach Resources Inc (AREXQ):企業の財務・戦略的SWOT分析
    Approach Resources Inc (AREXQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Dominion Energy Inc (D):企業の財務・戦略的SWOT分析
    Dominion Energy Inc (D) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Awarepoint Corp:医療機器:M&Aディール及び事業提携情報
    Summary Awarepoint Corp (Awarepoint) is a healthcare technology company that provides real time location system. The company offers technology, software and managed services. It provides location software packages for mobile phones and other electronics. Awarepoint’s software packages provide patien …
  • Carraro Spa:戦略・SWOT・企業財務分析
    Carraro Spa - Strategy, SWOT and Corporate Finance Report Summary Carraro Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Align Technology Inc (ALGN):企業の財務・戦略的SWOT分析
    Align Technology Inc (ALGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • BankNordik P/F:企業の戦略・SWOT・財務分析
    BankNordik P/F - Strategy, SWOT and Corporate Finance Report Summary BankNordik P/F - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Origin Energy Ltd (ORG)-石油・ガス分野:企業M&A・提携分析
    Summary Origin Energy Limited (Origin Energy) is an integrated energy company. It generates, supplies and distributes electricity; explores and develops natural gas reserves; and produces and sells gas. The company generates electricity from natural-gas fired, coal-fired, wind, solar, pumped water s …
  • Nanyang Technological University:企業の戦略的SWOT分析
    Nanyang Technological University - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Cheetah Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cheetah Medical Inc (Cheetah Medical) is a provider of non-invasive hemodynamic monitoring technologies. The company provides products such as Cheetah Nicom prewired sensors and Starling SV systems. It also provides Starling SV system accessories such as monitors and sensors, replacement par …
  • Singularlogic Information Systems And Software Technology S.A.:企業の戦略的SWOT分析
    Singularlogic Information Systems And Software Technology S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees …
  • IPCA Laboratories Ltd (IPCALAB):製薬・医療:M&Aディール及び事業提携情報
    Summary IPCA Laboratories Ltd (IPCA) is a pharmaceutical company which manufactures and markets active pharmaceutical ingredients, generics and formulations for various therapeutic areas. The company’s active pharmaceutical ingredients include anti-hypertensive, anti-malarial, diuretic and anthelmin …
  • A-Sonic Aerospace Limited:企業の戦略・SWOT・財務分析
    A-Sonic Aerospace Limited - Strategy, SWOT and Corporate Finance Report Summary A-Sonic Aerospace Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆